New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 18, 2014
12:42 EDTGOOG, KND, IBM, RP, SWKS, GE, AMD, GTIV, GOOGLOn The Fly: Midday Wrap
Stocks on Wall Street began the session in positive territory and have remained there throughout the morning. The averages moved in a narrow range for most of the opening hour of the session but spurted to higher levels during the second hour. Investors appear to be using yesterday’s sell-off as a buying opportunity, despite the ongoing events in Russia and Israel that largely contributed to yesterday’s action. ECONOMIC EVENTS: The first release of the University of Michigan consumer sentiment index for July fell to 81.3 after ending June with an 82.5 reading. The leading economic indicator index rose 0.3% to 102.2, which was a bit below the forecast for an increase of 0.5%. COMPANY NEWS: Class A shares of Google (GOOGL) advanced over 3% after the search giant reported quarterly revenue that beat expectations last night. Following its report, at least three Wall Street research firms raised their price targets on the stock, while noted tech analyst Collin Gillis of BGC Financial upgraded the stock to Buy from Hold... Dow component General Electric (GE) reported second quarter EPS of 39c, matching the consensus forecast, and revenue that just missed the consensus view of analysts. The company also reported that it is targeting the initial public offering of IPO of Synchrony Financial (SYF), its North American Retail Finance business, for July. In the IPO, Synchrony is offering 125M shares of its common stock, which will be listed on the New York Stock Exchange under the symbol “SYF,” and anticipates that the IPO price of the shares will be between $23.00 and $26.00 per share... Another Dow member, IBM (IBM), fell 0.4% after reporting adjusted Q2 earnings per share and revenue that beat expectations. Afterward, Cantor said it thinks the worst is over for the company and reiterated its Buy rating on the shares, though Societe Generale downgraded IBM to Sell from Hold and Credit Suisse said IBM continues to be driven by less revenue growth and kept its Underperform rating and $160 price target on Big Blue's stock. MAJOR MOVERS: Among the notable gainers was Skyworks (SWKS), which gained 14% after reporting third quarter results and fourth quarter guidance above analyst estimates and seeing no less than five analyst firms raise their price targets on its stock. Also higher was Gentiva Health (GTIV), which rose 14% after it announced that its board unanimously determined to reject the partial tender offer from Kindred Healthcare (KND) to acquire 14.9% of the outstanding shares of Gentiva for a price of $16.00 per share in cash and disclosed that it has received a $17.25 per share, all-cash takeover proposal from a "recognized owner, operator and investor in the sector." After the announcement, shares of Kindred fell 2%. Also lower following their earnings reports were RealPage (RP), which fell over 21%, and Advanced Micro Devices (AMD), which dropped nearly 18%. INDEXES: Near midday, the Dow was up 107.05, or 0.63%, to 17,083.86, the Nasdaq was up 57.98, or 1.33%, to 4,421.43, and the S&P 500 was up 17.04, or 0.87%, to 1,975.16.
News For GOOGL;GE;IBM;GTIV;SWKS;KND;AMD;RP;GOOG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
January 13, 2015
07:04 EDTIBMFederal court confirms halt to sales of chips used by SanDisk, IBM, others
Subscribe for More Information
06:45 EDTSWKSSkyworks upgraded to Outperform from Market Perform at BMO Capital
Subscribe for More Information
06:33 EDTIBMTeradata set to acquire Appoxee for about $20M, WSJ reports
Teradata (TDC) will buy Appoxee, a Tel Aviv-based mobile-marketing-automation startup, for around $20M, The Wall Street Journal reports, citing two sources. Teradata rival IBM (IBM) acquired Xtify, a mobile-marketing company, in 2013. Reference Link
06:30 EDTIBMCourt order bars sales of chips used by SanDisk and IBM, WSJ reports
Subscribe for More Information
January 12, 2015
17:55 EDTAMDAMD executives LaForce, Naik, Byrne depart the company, Barron's says
AMD's Chief Marketing Officer Colette LaForce, Chief Strategy Officer Raj Naik, and John Byrne the General Manager, Computing and Graphics Business Group have departed the company, reports Barron's in their 'Tech Trader Daily' column, citing a regulatory filing and an emailed statement by the company. Reference Link
17:53 EDTAMDAMD General Manager, Computing and Graphics Business Group departs
Subscribe for More Information
13:14 EDTGOOGL, GOOGAnalysts take opposite sides in regards to Google shares
Subscribe for More Information
11:51 EDTIBMIBM results seen being hurt by continued dollar strength
Subscribe for More Information
11:19 EDTGOOGGoogle set to provide real-time translation via Translate app, NY Times reports
Subscribe for More Information
10:00 EDTGOOGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:40 EDTGOOGGoogle no longer fixing older Android security flaws, WSJ reports
Subscribe for More Information
09:22 EDTGOOG23andMe announces collaboration with Pfizer
Google (GOOG)-backed 23andMe announced an agreement with Pfizer (PFE) that will provide Pfizer with access to 23andMe’s research platform, including services and Research Portal analysis of 23andMe’s genotyped population of over 800,000 individuals, of which more than 80 percent have consented to participate in research. 23andMe’s Research Portal enables qualified and approved scientists outside of 23andMe the opportunity to leverage the company’s unique research model while still protecting the privacy and security of 23andMe’s customers. As a part of the agreement, the companies will collaborate on certain genome-wide association studies, surveys, and clinical trial recruitment. One of these collaborations will be a longitudinal study to better understand the genetics of lupus. This study will entail enrollment and genotyping of 5,000 people into a new lupus research community, and include the integration of medical records, targeted bio-sampling along with genetic information for all participants. This announcement follows a collaboration between 23andMe and Pfizer to enroll 10,000 people with Inflammatory Bowel Disease in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Nearly 4,000 patients have been enrolled in the community since August 2014.
08:21 EDTGOOG, GOOGLApple poised to gain market share, says JMP Securities
Subscribe for More Information
08:02 EDTGOOG, GOOGLGoogle shares undervalued, says Bernstein
Subscribe for More Information
07:52 EDTIBMIBM to undertake biggest re-organization in company history, Register says
Subscribe for More Information
07:52 EDTIBMIBM price target lowered to $130 from $144 at Jefferies
Jefferies lowered its price target for IBM shares to $130 after cutting its estimates to reflect the strengthening of the dollar against almost every other major currency worldwide since the tech giant reported Q3 results. Jefferies believes consensus estimates for IBM need to come down as the company deals with enterprises increasingly allocating investments away from traditional Software and IT Outsourcing toward investments in Cloud, Mobile and and Social initiatives. The firm reiterates an Underperform rating on IBM.
07:38 EDTGOOGL, GOOGGoogle downgraded to Neutral from Overweight at Atlantic Equities
Subscribe for More Information
07:35 EDTIBMNational Retail Federation to hold a trade show
Subscribe for More Information
06:46 EDTGOOGL, GOOGGoogle downgraded to Neutral from Overweight at Atlantic Equities
Subscribe for More Information
06:44 EDTAMDIntel shares could trade higher near-term, says Citigroup
Citigroup says shares of Intel (INTC) could move higher over the near-term given the high short interest in the name and likely above guidance earnings results. Citi says its channel checks indicate the PC market remains stable and that Intel continues to gain share from AMD (AMD). The firm keeps a Neutral rating on Intel, however, pointing out its 2015 estimates remain below consensus.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use